Insights

Loading spinner
Gathering insights about Dermapharm Holding SE

Dermapharm Holding SE Tech Stack

Dermapharm Holding SE uses 8 technology products and services including Google Analytics, Contao, Font Awesome, and more. Explore Dermapharm Holding SE's tech stack below.

  • Google Analytics
    Analytics
  • Contao
    Content Management System
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Piwik
    System Analytics & Monitoring
  • Bootstrap
    UI Frameworks
  • Apache HTTP Server
    Web Servers

Dermapharm Holding SE's Email Address Formats

Dermapharm Holding SE uses at least 1 format(s):
Dermapharm Holding SE Email FormatsExamplePercentage
First.Last@dermapharm.deJohn.Doe@dermapharm.de
50%
First.Last@dermapharm.deJohn.Doe@dermapharm.de
50%

Frequently Asked Questions

Where is Dermapharm Holding SE's headquarters located?

Minus sign iconPlus sign icon
Dermapharm Holding SE's main headquarters is located at Lil-Dagover Ring 7 Grünwald, Bayern 82031 DE. The company has employees across 5 continents, including EuropeOceaniaAsia.

What is Dermapharm Holding SE's official website and social media links?

Minus sign iconPlus sign icon
Dermapharm Holding SE's official website is dermapharm.de and has social profiles on LinkedIn.

How much revenue does Dermapharm Holding SE generate?

Minus sign iconPlus sign icon
As of December 2024, Dermapharm Holding SE's annual revenue reached $1.2B.

What is Dermapharm Holding SE's NAICS code?

Minus sign iconPlus sign icon
Dermapharm Holding SE's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Dermapharm Holding SE have currently?

Minus sign iconPlus sign icon
As of December 2024, Dermapharm Holding SE has approximately 1K employees across 5 continents, including EuropeOceaniaAsia. Key team members include Head Of Investor Relations & Corporate Communications: B. H.Head Of Finance: S. T.Cfo/ Cco: C. D.. Explore Dermapharm Holding SE's employee directory with LeadIQ.

What industry does Dermapharm Holding SE belong to?

Minus sign iconPlus sign icon
Dermapharm Holding SE operates in the Pharmaceutical Manufacturing industry.

What technology does Dermapharm Holding SE use?

Minus sign iconPlus sign icon
Dermapharm Holding SE's tech stack includes Google AnalyticsContaoFont AwesomejQueryPHPPiwikBootstrapApache HTTP Server.

What is Dermapharm Holding SE's email format?

Minus sign iconPlus sign icon
Dermapharm Holding SE's email format typically follows the pattern of . Find more Dermapharm Holding SE email formats with LeadIQ.

When was Dermapharm Holding SE founded?

Minus sign iconPlus sign icon
Dermapharm Holding SE was founded in 1991.
Dermapharm Holding SE

Dermapharm Holding SE

Pharmaceutical ManufacturingBayern, Germany1001-5000 Employees

Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand-name products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States.

In the "Branded pharmaceuticals and other healthcare products" segment, Dermapharm has approximately 1,300 marketing authorisations with more than 380 active pharmaceutical ingredients. Dermapharm's portfolio of pharmaceuticals, medical devices and food supplements are tailored to selected therapeutic areas in which the Company is a market leader, especially in Germany.

In the "Herbal extracts" segment, Dermapharm can tap the expertise of the Spanish company Euromed S.A., a leading global manufacturer of herbal extracts and plant-based active ingredients for the pharmaceuticals, nutraceuticals, foodstuffs and cosmetics industries. At the beginning of 2022, the segment was expanded to include Germany-based C³ Group, which develops, manufactures and markets synthetic cannabinoids. C³ Group is the market leader for dronabinol in Germany and Austria.

Dermapharm's business model also includes the "Parallel import business" segment that operates under the "axicorp" brand. Based on revenue, axicorp was among the top five parallel import companies in Germany in 2021.

With a consistent R&D strategy and numerous successful product and company acquisitions and by stepping up its internationalisation efforts, Dermapharm has continuously optimised its business over the past 30 years and sought external growth opportunities in addition to organic growth. Dermapharm is firmly committed to continuing on this profitable growth course in the future.

Section iconCompany Overview

Headquarters
Lil-Dagover Ring 7 Grünwald, Bayern 82031 DE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1991
Employees
1001-5000

Section iconFunding & Financials

  • $1B

    Dermapharm Holding SE's revenue is in the range of $1B

Section iconFunding & Financials

  • $1B

    Dermapharm Holding SE's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.